Urine Opioid Dependency Panel (UODP) 1

Similar documents
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Prescription Drug Monitoring Reference Guide: 2017

Physician s Reference for Urine and Blood Drug Testing and Interpretation

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

The Drug Testing Process. Employer or Practice

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

Urine Drug Testing Methods 3-5

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Drugs of Abuse I Serum

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

PARTICIPANT GENERAL INFORMATION

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Laboratory Service Report

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

INTERPATH LABORATORY, INC. TEST UPDATES

LC Application Note. Dangerous driver?

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Prescription Drug Abuse: Colorado and Nationwide

Pain Medication Management Program Supports Patient Outcomes and Adherence

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Forensic Toxicology Scope of Testing and Detection Limits

Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Application for Admission

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Drug Adherence Assessment Report

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Pain Medication Management Program Monitors Patient Compliance

Urine Drug Screening: The Essentials of Interpretation

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Application for Admission

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

nextgen precision Test Report

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Toxicology Testing Is it a Good Fit for Your Laboratory? Rebecca Kenner, BA, MT, DLM(ASCP) Leigh Ann Smith, BS, MLS(ASCP), CLS

Urine drug testing it s not always crystal clear

Validation of an Automated Method to Remove

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

OTHER DRUGS OF ABUSE Source:

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

METHAMPHETAMINE & AMPHETAMINE

Pinellas County Forensic Laboratory. Annual Report 2006

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry

NIDA Quick Screen V1.0F1

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Drugs Found in Medical Examiner Cases

Welcome to LabSolutions, LLC

Lesson 5 - Regulations and Standards Assignment Answer Key

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Interpretation of Pain Management Testing Results Using Case Examples

Xyrem (Sodium Oxybate)

Toxicology Practice and Procedure Handbook

How: or, Behind the Curtain.

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

European Guidelines for Workplace Drug Testing in UrineandOral fluid

Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.

Patient Instructions

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2007) Substance Use Disorders E. 2

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

NIDA-Modified ASSIST Prescreen V1.0 1

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

CNS DEPRESSANT OVERDOSE

PROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH

APPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Drugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler

Evaluation of the Integrated E-Z Split Key Cup II for Rapid Detection of Twelve Drug Classes in Urine

2015 Annual Physician Notice

Texas Prior Authorization Program Clinical Edit Criteria

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives

! Drug Screen Quick Reference Guide

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Cross-reactivity reactivity in EMIT

Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview

Drug Overdose Fatality Surveillance System (DOFSS) 2015 Annual Report

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

ToxCup Drug Screen Cup Step-by Step Instructions

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Preventing Medication Diversion

Transcription:

Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth, Uppers) (MDA) A prescription drug; also a metabolite of methamphetamine Metabolite of Selegiline; Metabolized to amphetamine Metabolite of methylenedioxymethamphetamine 2 2 2 Methylenedioxymethamphetamine (Ecstasy, MDMA) Metabolized to methylenedioxyamphetamine 2 Benzodiazepines 7-Aminoclonazepam Metabolite of clonazepam (Rivotril) 7-Aminonitrazepam Metabolite of nitrazepam (Mogadon) Alphahydroxyalprazolam Metabolite of alprazolam (Xanax) Alphahydroxytriazolam Metabolite of triazolam (Halcion) Bromazepam Lectopam Demoxepam Diazepam Valium Metabolite of chlordiazepoxide (Librium); further metabolized to nordiazepam Metabolized to nordiazepam, temazepam, oxazepam Controlled Copy: Date Printed: Initials: Page 1 of 12

Drug Testing Panels Benzodiazepines continued Lorazepam Ativan Nordiazepam Oxazepam Serax Temazepam Restoril Cocaine Related Compounds Metabolite of diazepam (Valium) and chlordiazepoxide (Librium); further metabolized to oxazepam Metabolite of diazepam, temazepam, chlordiazepoxide Metabolite of diazepam; metabolized to oxazepam Benzoylecgonine Metabolite of cocaine 100 Opioids 6-Acetylmorphine 6-monoacetylmorphine (6-MAM) Heroin metabolite 5 Codeine Morphine Hydrocodone Vicodin Tylenol with codeine, Tylenol No. 2, Tylenol No. 3, Tylenol No. 4, codeine phosphate and others MS Contin, M-Eslon, Kadian and others Metabolized to morphine and hydrocodone Metabolite of codeine; metabolized to hydromorphone Metabolite of codeine; metabolized to hydromorphone Hydromorphone Dilaudid, Hydromorph Contin, Jurnista Metabolite of hydrocodone Oxycodone Oxycontin, OxyNeo, Percocet, Percodan Metabolized to oxymorphone Controlled Copy: Date Printed: Initials: Page 2 of 12

Drug Testing Panels Opioids continued Oxymorphone Metabolite of oxycodone, prescription not available in Canada Fentanyl Duragesic Metabolized to norfentanyl 5 o Norfentanyl Metabolite of fentanyl 5 Buprenorphine Butrans, Suboxone, Belbuca Metabolized to norbuprenorphine 10 o Norbuprenorphine Metabolite of buprenorphine 10 Methadone Methadose Metabolized to EDDP o EDDP 3 Metabolite of methadone 1. Sample hydrolysis performed prior to analysis by liquid chromatography/mass spectrometry (LC-MS/MS) allowing detection of both free and conjugated drug. A positive result does not give any indication as to level of impairment/intoxication, route of administration or ingested dose. Determining concentration of drug (i.e. the drug level) in urine does not overcome these limitations. Concentrations are NOT reported. A negative result does not necessarily mean the urine is drug free. A negative result may mean: the sample is drug free or drugs are present but were not at or above the cut-off concentrations listed or the drug present in the sample is not detected by this method. 2. The cut-off concentration is the concentration that distinguishes whether a drug is reported as detected or not detected. 3. EDDP = 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine Controlled Copy: Date Printed: Initials: Page 3 of 12

Drug Testing Panels Urine General Panel (UGTP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth, Uppers) (MDA) A prescription drug; also a metabolite of methamphetamine Metabolite of Selegiline; Metabolized to amphetamine Metabolite of methylenedioxymethamphetamine 2 2 2 Methylenedioxymethamphetamine (Ecstasy, MDMA) Metabolized to methylenedioxyamphetamine 2 Paramethoxyamphetamine (PMA) Metabolite of paramethoxymethamphetamine Paramethoxymethamphetamine (PMMA) Metabolized to paramethoxyamphetamine Analgesics Tapentadol Nucynta Tramadol Tramacet Metabolized to O-desmethyltramadol o O-desmethyltramadol Metabolite of tramadol Controlled Copy: Date Printed: Initials: Page 4 of 12

Drug Testing Panels Anesthetics Ketamine Metabolized to norketamine 100 Anticonvulsants o Norketamine Metabolite of ketamine 100 Gabapentin Neurontin Antihistamine Diphenhydramine\ Dimenhydrinate Barbiturates Low concentrations not detected by this method Dimenhydrinate is the 8-chlorotheophylline salt of diphenhydramine 10,000 Butalbital Fiorinal (with codeine in some preparations) 300 Phenobarbital Luminal, phenobarbitone 300 Benzodiazepines 7-Aminoclonazepam Metabolite of clonazepam (Rivotril) 7-Aminonitrazepam Metabolite of nitrazepam (Mogadon) Alphahydroxyalprazolam Metabolite of alprazolam (Xanax) Controlled Copy: Date Printed: Initials: Page 5 of 12

Drug Testing Panels Benzodiazepines continued Alphahydroxytriazolam Metabolite of triazolam (Halcion) Bromazepam Lectopam Clobazam Frisium Metabolized to norclobazam o Norclobazam Metabolite of clobazam Demoxepam Diazepam Valium Metabolite of chlordiazepoxide (Librium); further metabolized to nordiazepam Metabolized to nordiazepam, temazepam, oxazepam Lorazepam Ativan Midazolam Versed Metabolized to 1-hydroxymidazolam o 1-Hydroxymidazolam Metabolite of midazolam Nordiazepam Oxazepam Serax Temazepam Restoril Metabolite of diazepam (Valium) and chlordiazepoxide (Librium); further metabolized to oxazepam Metabolite of diazepam, temazepam, chlordiazepoxide Metabolite of diazepam; metabolized to oxazepam Controlled Copy: Date Printed: Initials: Page 6 of 12

Drug Testing Panels Cannabinoids Marijuana Metabolite (THC COOH) (11-nor- 9 -tetrahydrocannabinol-9- carboxylic acid) Cutting Agents Sativex (Cannabis, Cannabinoids, Weed, Grass, THC) Metabolite of tetrahydrocannabinol (THC) 15 Levamisole Cutting agent may cause profound neutropenia Phenacetin Cutting agent 25 Xylazine Cutting agent Cocaine and Related Compounds Cocaine (crack, blow, snow) Metabolized to a variety of metabolites Benzoylecgonine Metabolite of cocaine 100 Cocaethylene Opioids Metabolite arising from simultaneous use of cocaine and ethanol 25 6-Acetylmorphine 6-monoacetylmorphine (6-MAM) Metabolite of heroin (diacetylmorphine) 5 Codeine Morphine Tylenol with codeine, Tylenol No. 2, Tylenol No. 3, Tylenol No. 4, codeine phosphate and others MS Contin, M-Eslon, Kadian and others Metabolized to morphine and hydrocodone Metabolite of codeine; metabolized to hydromorphone Controlled Copy: Date Printed: Initials: Page 7 of 12

Drug Testing Panels Opioids continued Hydrocodone Vicodin Metabolite of codeine; metabolized to hydromorphone o Norhydrocodone Metabolite of hydrocodone Hydromorphone Dilaudid, Hydromorph Contin, Jurnista Metabolite of hydrocodone Oxycodone Oxycontin, OxyNeo, Percocet, Percodan Metabolized to noroxycodone and oxymorphone o Noroxycodone Metabolite of oxycodone Oxymorphone Prescription not available in Canada Metabolite of oxycodone o Noroxymorphone Metabolite of oxymorphone Fentanyl Duragesic Metabolized to norfentanyl 5 o Norfentanyl Metabolite of fentanyl 5 Norcarfentanil Metabolite of carfentanil and remifentanil 0.5 Buprenorphine Butrans, Suboxone, Belbuca Metabolized to norbuprenorphine 10 o Norbuprenorphine Metabolite of buprenorphine 10 Methadone Methadose Metabolized to EDDP Controlled Copy: Date Printed: Initials: Page 8 of 12

Drug Testing Panels Opioids continued o EDDP 3 Metabolite of methadone Meperidine Demerol Metabolized to normeperidine 100 o Normeperidine Metabolite of meperidine 100 Sedative-Hypnotics (Miscellaneous) Zopiclone Imovane Stimulants (Miscellaneous) Methylphenidate Biphentin, Concerta, Ritalin Metabolized to ritalinic acid 100 Ritalinic Acid Metabolite of methylphenidate 0 1. Sample hydrolysis performed prior to analysis by liquid chromatography/mass spectrometry (LC-MS/MS) allowing detection of both free and conjugated drug. A positive result does not give any indication as to level of impairment/intoxication, route of administration or ingested dose. Determining concentration of drug (i.e. the drug level) in urine does not overcome these limitations. Levels are NOT reported. A negative result does not necessarily mean the urine is drug free. A negative result may mean: the sample is drug free or drugs are present but were not at or above the cut-off concentrations listed or the drug present in the sample is not detected by this method. 2. The cut-off concentration is the concentration that distinguishes whether a drug is reported as detected or not detected. 3. EDDP = 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine Controlled Copy: Date Printed: Initials: Page 9 of 12

Drug Testing Panels Controlled Copy: Date Printed: Initials: Page 10 of 12

Drug Testing Panels Controlled Copy: Date Printed: Initials: Page 11 of 12

Drug Testing Panels Controlled Copy: Date Printed: Initials: Page 12 of 12